GLP-1 Dosing Frequency for Weight Loss

Q: How much do compounded GLP-1 medications cost at different dose strengths?

PlexusDx compounded semaglutide injections range $179–$229/month, oral semaglutide from $249/mo, and tirzepatide options $229–$509/month depending on formulation and dose. All products are sourced from licensed 503A compounding pharmacies.

Last reviewed: May 14, 2026

Last updated: May 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 medications for weight loss are administered on a weekly injection schedule or as daily oral tablets, with dose escalation protocols designed to improve tolerability and efficacy over 16–20 weeks. Standard injectable protocols begin at 0.25 mg weekly and increase by 0.25 mg increments every one to two weeks, depending on individual tolerance and clinical response.

Understanding your prescribed dosing frequency and escalation timeline is critical before starting treatment. PlexusDx's precision-wellness approach incorporates biomarker context and genetic predispositions in peptide pathways to help you and your provider make more informed decisions about dosing strategy and expected tolerability.

Standard Dosing Intervals: Weekly Injections vs. Daily Oral Options

Injectable GLP-1 agonists follow a once-weekly dosing pattern, allowing consistent receptor engagement and metabolic effect throughout the week. This schedule simplifies adherence and reduces injection frequency compared to older peptide therapies. Oral formulations require daily administration but offer convenience for patients who prefer avoiding needles.

Both delivery methods achieve dose escalation over 4–5 months to reach therapeutic targets. PlexusDx offers compounded semaglutide injections starting at $179/month and oral semaglutide from $249/mo, with tirzepatide options ranging $279/mo depending on formulation and dose strength.

Dose Escalation Protocols and Timeline Considerations

Dose escalation in GLP-1 therapy follows a structured protocol to balance efficacy and tolerability. Most patients progress through predefined dose increments over 16–20 weeks, though individual timelines may vary based on gastrointestinal tolerance and metabolic response. Staying with a consistent schedule supports steady weight loss without overwhelming side effects.

Week Range	Typical Dose	Clinical Goal	Dosing Frequency
Weeks 1–4	0.25 mg or 2.5 mg oral	Tolerance assessment, GI adaptation	Weekly injection or daily oral
Weeks 5–8	0.5 mg or 5 mg oral	Gradual receptor engagement	Weekly injection or daily oral
Weeks 9–16	1.0–1.7 mg or 10 mg oral	Efficacy optimization, continued tolerability	Weekly injection or daily oral
Week 16+	Maintenance dose (0.5–2.4 mg or 10–15 mg)	Sustained weight loss and metabolic effect	Ongoing weekly or daily

How Individual Tolerance Affects Your Dosing Schedule

Not all patients tolerate standard escalation timelines identically. Nausea, vomiting, or loss of appetite—common initial side effects—may require slower dose increases or temporary plateau at a lower dose. Your provider should monitor gastrointestinal symptoms and adjust your schedule accordingly to maximize benefit while minimizing adverse effects.

Slower escalation does not mean inferior outcomes; it reflects your body's individual adaptation timeline. Some patients achieve meaningful weight loss at 1.0 mg weekly while others reach maximum benefit at 2.4 mg. Open communication with your provider about tolerability ensures your dosing plan aligns with your comfort and health.

Safety Monitoring and When Dosing Adjustments Are Necessary

Regular provider check-ins are essential when starting or adjusting GLP-1 therapy. Your healthcare team should assess tolerability at each dose increase, monitor for pancreatitis, gallbladder complications, and dehydration, and review any personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. These safety markers may influence dosing recommendations.

Certain medical conditions—severe kidney disease, active diabetic retinopathy, or significant gastrointestinal motility disorders—require careful provider assessment before initiating therapy. Dosing frequency and dose strength should always be personalized based on your complete medical history, current medications, and individual metabolic profile.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context regarding your genetic predispositions in key GLP-1 receptor and metabolic pathways, including variants in GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609. This information can support a more informed conversation with your provider about anticipated tolerability and potential dosing strategy, though genetic predispositions should be interpreted alongside your complete clinical picture.

The genetic test reveals predispositions in peptide response pathways—not exact medication response or guaranteed outcomes. A patient with certain GLP1R variants may experience different initial tolerability compared to another patient, informing whether a more conservative escalation schedule might be appropriate. However, environmental factors, comorbidities, and individual physiology remain equally important determinants of your actual treatment response.

Combining genetic insights with your provider's clinical judgment and ongoing monitoring creates a more personalized foundation for dosing decisions. When discussing your treatment plan, share your genetic predispositions test results with your healthcare team so they can integrate this information into your individualized protocol.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard dosing frequency for GLP-1 weight loss medications?

Most injectable GLP-1 agonists are dosed once weekly, while oral formulations are taken daily. Both follow dose escalation protocols over 16–20 weeks, starting at low doses and increasing gradually based on tolerability and clinical response.

Can my dosing schedule be adjusted if I experience side effects?

Yes. If nausea, vomiting, or severe loss of appetite occurs, your provider may pause escalation, reduce the dose, or extend the interval between increases. Slower escalation is a legitimate, effective approach supported by clinical evidence and may improve long-term adherence.

How much do compounded GLP-1 medications cost at different dose strengths?

PlexusDx compounded semaglutide injections range $149/mo, oral semaglutide from $249/mo, and tirzepatide options $279/mo depending on formulation and dose. All products are sourced from licensed 503A compounding pharmacies.

What happens if I miss a weekly injection or daily dose?

If you miss a weekly injection, take it as soon as possible within 2 days; if beyond 2 days, skip and resume your regular schedule. For daily oral doses, take the missed dose as soon as remembered unless it's almost time for the next dose. Consult your provider for specific guidance on your regimen.

Can genetic testing predict how I will respond to different GLP-1 dosing schedules?

The Precision Peptide Genetic Test identifies predispositions in GLP-1 receptor and metabolic pathways that may inform tolerability expectations, but it does not predict exact medication response. Genetic findings should be discussed with your provider alongside your medical history to support personalized dosing decisions.

How Often Do You Use Ozempic for Weight Loss?